Skinvisible (SKVI) Liabilities and Shareholders Equity (2010 - 2026)

Skinvisible has disclosed Liabilities and Shareholders Equity across 17 years of filings, most recently posting $119419.0 for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $119419.0, down 20.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $523984.0 (down 15.41% YoY), and the FY2025 annual result was $127567.0, down 19.37% from the prior year.
• Liabilities and Shareholders Equity came in at $119419.0 for Q1 2026 at Skinvisible, down from $127567.0 in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $320590.0 in Q2 2022 to a low of $119419.0 in Q1 2026.
• The 5-year median for Liabilities and Shareholders Equity is $162869.0 (2023), against an average of $181005.6.
• Across the five-year window, Liabilities and Shareholders Equity surged 38.91% in 2022 and plunged 38.76% in 2023, its largest moves.
• Skinvisible's Liabilities and Shareholders Equity stood at $246793.0 in 2022, then plunged by 34.01% to $162869.0 in 2023, then slipped by 2.86% to $158217.0 in 2024, then fell by 19.37% to $127567.0 in 2025, then fell by 6.39% to $119419.0 in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $119419.0 (Q1 2026), $127567.0 (Q4 2025), and $133623.0 (Q3 2025), per Business Quant data.